IceCure enrols initial patients for ProSense cryoablation trial in US
IceCure Medical has enrolled its first two patients across two clinical centres in the US for the ChoICE study assessing its ProSense cryoablation system in low-risk breast cancer treatment.
The post IceCure enrols initial patients for ProSense cryoablation trial in US appeared first on Medical Device Network .